A PYMNTS Company

US: Bidding wars rise for global over-the-counter purchase

By  |  April 9, 2014

Pharmaceutical giants are vying to acquire the over-the-counter operations of US-based Merck & Co., but according to reports, one company is favorite to come out victorious.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    UK-based Reckitt Benckiser is seen by some experts to likely face less antitrust resistance over competing bidders, which include giants like Novartis, Bayer and Sanofi. Sources say the bidding is likely to top $12 billion.

    Bids for the company, which manufacturers popular products like Coppertone sunblock and Claritin allergy medicine, are due April 16, the sources said. Reckitt Benckiser surprised the industry in 2012 with its surprise bid for Schiff Nutrition, eventually beating out Bayer for the assets.

    Full Content: Businessweek

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.